Taevas
Sri LankaPersonal Care & Beauty
Product Registration
Market Access for Product-Registration in Sri Lanka
Taevas Life Sciences provides comprehensive market access strategies, ensuring your registered products achieve optimal commercial potential across diverse global healthcare systems. We navigate complex regulatory landscapes and payer environments to secu
Market
Global
Industry
Product-Registration
Regulator
International Health Authorities
Timeline
4-6 weeks (initial strategy development)
Deliverables
Strategic Market Access Plan, Global HTA Dossier, Payer Engagement Roadmap
What We Deliver
6 Pillars of Market Access for Global Product-Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence & Mapping
Thorough analysis of the diverse regulatory requirements and market entry pathways across key global regions. We identify specific hurdles and opportunities for your registered product.
Country-specific regulatory landscape analysis
Comparative analysis of registration timelines
Identification of fast-track opportunities
How It Works
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Initial Assessment & Scoping
We begin with a detailed understanding of your product, target markets, and existing registration status. This phase defines the scope and objectives of our market access engagement.
Market Snapshot
Market Overview: Global Product-Registration & Market Access Dynamics
Increasing Payer Scrutiny
Global payers are demanding higher levels of clinical and economic evidence to justify reimbursement, making robust HTA dossiers indispensable for product registration success.
Fragmented Global Landscape
Despite harmonization efforts, regulatory and reimbursement systems vary significantly by country, requiring nuanced, region-specific market access strategies for global products.
Value-Based Healthcare Imperative
The shift towards value-based healthcare models necessitates a clear demonstration of a product's real-world impact and cost-effectiveness beyond initial clinical trial data.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Comprehensive Global Market Access Strategy
A detailed roadmap outlining optimal pathways for product entry, pricing, and reimbursement across key international markets.
Health Technology Assessment (HTA) Dossier Compilation
Expertly crafted evidence packages tailored to meet the specific requirements of global HTA bodies, demonstrating clinical and economic value.
Payer & Stakeholder Engagement Plan
A strategic framework for identifying, engaging, and influencing key decision-makers to secure favorable reimbursement and access conditions.
Global Pricing & Reimbursement Framework
Guidance on developing sustainable pricing strategies that account for international reference pricing, local market nuances, and budget impact.
Who This Is For
Use Cases
Novel Biologic
Launching a Novel Oncology Biologic in Europe and Asia
A biotech company with a newly registered oncology biologic needed to navigate complex HTA processes in multiple European countries and rapidly evolving reimbursement landscapes in key Asian markets.
Outcome
Taevas developed region-specific HTA dossiers and payer engagement strategies, securing favorable reimbursement in 80% of target markets within 18 months of registration.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to transform your product registration into successful global market entry. Our expertise ensures your innovations reach the patients who need them most.
Accelerate Time to Market
Optimize Reimbursement & Pricing
Navigate Global Complexities with Confidence
Maximize Commercial Potential